BlackRock Investment Management’s Fibrocell Science Inc. FCSC Stock Holding History

BlackRock Investment Management’s Portfolio FCSC Stock Details FCSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$3K	Hold	301	–	–	﹤0.01%	3852
2016 Q3	$3K	Hold	301	–	–	﹤0.01%	3862
2016 Q2	$5K	Sell	301 -5,982	-95%	-$186K	﹤0.01%	3866
2016 Q1	$236K	Buy	6,283 +113	+2%	+$4.51K	﹤0.01%	3127
2015 Q4	$421K	Buy	6,170 +16	+0.3%	+$1.15K	﹤0.01%	3056
2015 Q3	$355K	Buy	6,154 +494	+9%	+$43.7K	﹤0.01%	3135
2015 Q2	$447K	Buy	5,660 +5,378	+1,907%	+$362K	﹤0.01%	3154
2015 Q1	$19K	Buy	282 +13	+5%	+$837	﹤0.01%	3463
2014 Q4	$10K	Hold	269	–	–	﹤0.01%	3695
2014 Q3	$12K	Sell	269 -1	-0.4%	-$47	﹤0.01%	3602
2014 Q2	$16K	Sell	270 -3,897	-94%	-$217K	﹤0.01%	3483
2014 Q1	$327K	Buy	4,167 +175	+4%	+$13.6K	﹤0.01%	3132
2013 Q4	$243K	Buy	3,992 +899	+29%	+$52.3K	﹤0.01%	3194
2013 Q3	$203K	Buy	3,093 +334	+12%	+$27K	﹤0.01%	3184
2013 Q2	$253K	Buy	+2,759	New	+$228K	﹤0.01%	3119

Other funds holding FCSC

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock Investment Management's FCSC Position: Q4 2016 in Review

BlackRock Investment Management held its Fibrocell Science Inc. (FCSC) position steady in Q4 2016 at 301 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #3852.

BlackRock Investment Management first reported a position in FCSC in Q2 2013 and has held it in 15 quarters since. The position peaked at $447K in Q2 2015. 30 funds tracked by Wall St. Rank hold FCSC as of Q4 2016.

BlackRock Investment Management held 301 shares of Fibrocell Science Inc. worth $3K as of Q4 2016.
BlackRock Investment Management left its Fibrocell Science Inc. share count unchanged in Q4 2016.
Fibrocell Science Inc. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3852 holding.
BlackRock Investment Management first reported a position in Fibrocell Science Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Investment Management's Fibrocell Science Inc. position peaked at $447K in Q2 2015.
30 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.